PHIAN Stock Chart & Stats
$479.54
$0.00(0.00%)
At close: 4:00 PM EDT
$479.54
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$330.00 - $504.33
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$404.31B
Enterprise Value$28.72K
Total Cash (Recent Filing)$1.79B
Total Debt (Recent Filing)$7.46B
Price to Earnings (P/E)18.1
Beta0.53
Next Earnings
Nov 03, 2026EPS Estimate
7.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.17
Shares Outstanding982,884,770
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$500.28Price Target Upside4.32% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)32.12
Revenue Forecast (FY)$352.95B
Bulls Say, Bears Say
Bulls Say
Profitability And Revenue RecoveryThe return to profitability alongside renewed revenue growth indicates that Philips has regained operating traction after its loss-making period. Positive earnings and sales momentum provide internal resources to support investment, customer relationships, and continued recovery over the next several quarters.
Manageable LeverageStable, moderate leverage and a larger equity base give Philips meaningful financial resilience relative to its debt obligations. This supports continued investment in healthcare technology and reduces the balance-sheet constraints that could otherwise limit strategic flexibility during uneven operating conditions.
Installed-Base And Service ModelRevenue from maintenance, upgrades, software, and multi-year service arrangements adds recurring elements beyond upfront equipment sales. Philips’s installed base can therefore deepen customer relationships, support ongoing revenue and improve the durability of its healthcare business model.
Bears Say
Deteriorating Free Cash Flow GrowthAlthough Philips is generating substantial cash in absolute terms, the sharp decline in free cash flow versus the prior period weakens confidence in near-term cash conversion. If sustained, this could reduce internally funded investment capacity and make reported earnings less dependable as a funding source.
Earnings And Margin VolatilityThe recent recovery has not yet demonstrated consistent earnings durability because Philips has experienced substantial profitability swings and remains below its earlier margin peak. Continued volatility can complicate planning, reduce confidence in normalized earnings, and limit operating leverage over the medium term.
Historical Equity And Return PressureThe decline in equity and several years of negative returns show that Philips has carried meaningful financial and operating pressure despite its latest recovery. A renewed deterioration could weaken shareholder capital and constrain the company’s ability to absorb further earnings setbacks.
Koninklijke Philips N.V. News
PHIAN FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was $330.00 and its highest was $504.33 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is $404.31B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is Nov 03, 2026 which is in 50 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on Jul 27, 2026. The company reported $9.671 earnings per share for the quarter, beating the consensus estimate of $7.342 by $2.329.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Undervalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. does not currently pay dividends.
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 7.11.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 982,884,770 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of $9.671 in its last earnings report, beating expectations of $7.342. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in MX:PHIAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
PHIAN Stock 12 Month Forecast
Average Price Target
$500.28
▲(4.32% Upside)